While normal ovarian surface cells do not express CLDN3 and CLDN4 these two proteins are up-regulated and expressed at high levels in as many as 92% of ovarian cancers presumably as a result of the MET [18], [22], [48]. This evidence concerns the gene CLDN3 and ovarian carcinoma.